Hostname: page-component-6bf8c574d5-w79xw Total loading time: 0 Render date: 2025-02-17T15:01:18.370Z Has data issue: false hasContentIssue false
  • English
  • Français

The emerging story of a human parvovirus-like agent

Published online by Cambridge University Press:  25 March 2010

M. J. Anderson
M. J. Anderson
Affiliation:
Department of Medical Microbiology, The Rayne Institute, King's College Hospital Medical School, London SE5 8RX.
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

It is now seven years since Cossart and her co-workers reported finding a novel parvovirus-like agent (PVLA) infecting man. Although this virus was found as a systemic infection in both Dr Cossart's eleven subjects and a further four subjects described subsequently (Paver & Clarke, 1976; Schneerson, Mortimer & Vandervelde, 1980) it was not until 1981 that a clearly defined clinical syndrome was identified as attributable to infection with this agent. Work in the Departments of Microbiology and Haematology, King's College Hospital Medical School and collaboration with the MRC laboratory at Kingston, Jamaica has shown that infection with the PVLA is the major cause of aplastic crisis in children with sickle cell anaemia (Sergeant et al. 1981, Anderson et al. 1982a, b).

Type
Special Article
Information
Journal of Hygiene , Volume 89 , Issue 1 , August 1982 , pp. 1 - 8
Copyright
Copyright © Cambridge University Press 1982

References

Anderson, M. J., Davis, L. R., Hodgson, J., Jones, S. E., Murtaza, L., Pattison, J. R., Stroud, C. E. & White, J. M. (1982 a). The occurence of infection with a parvovirus-like agent in children with sickle cell anaemia during a two year period. Journal of Clinical Pathology (In the Press).CrossRefGoogle Scholar
Anderson, M. J., Davis, L. R., Jones, S. E. & Pattison, J. R. (1982 b). The development and use of an antibody capture radioimmunoassay for specific IgM to a human parvovirus-like agent. Journal of Hygiene, 88, 309–324.CrossRefGoogle ScholarPubMed
Anderson, R. M. & May, R. M. (1982). The control of communicable diseases by age-specific immunisation schedules. Lancet i, 160.CrossRefGoogle Scholar
Cant, B. & Widdows, T. (1975). Abstract from Conference of the International Society of Blood Transfusion, p. 73.Google Scholar
Cossart, Y. E. (1977). Virus Hepatitis and its Control, p. 133. London. Baillière Tindall.Google Scholar
Cossart, Y. E., Field, A. M., Cant, B. & Widdows, D. (1975). Parvovirus-like particles in human sera. Lancet i, 72–73.CrossRefGoogle Scholar
Edwards, J. M. B., Kessel, I., Gardner, S. K., Eaton, B. R., Pollock, T. M., Gibson, P., Woodroof, M. & Porter, A. D. (1981). A study of antibodies to five viruses in sera from 210 acute admissions to a paediatric unit. EB virus, hepatitis A virus, parvovirus-like B19 and polyoma virus BK and JC. Abstract of European Association Against Virus Diseases, p. 14.Google Scholar
Mengeling, W. L., Paul, P. S. & Brown, T. T. (1981). Transplacental infection and embryonic death following exposure to porcine parvovirus near the time of conception. Archives of Virology 65, 55–62.CrossRefGoogle Scholar
Paver, W. K. & Clarke, S. K. R. (1976). Comparison of human fecal and serum parvo-like viruses. Journal of Clinical Microbiology 4, 67–70.CrossRefGoogle ScholarPubMed
Paver, W. K., Caul, E. O., Ashley, C. R. & Clarke, S. K. R. (1973). A small virus in human faeces. Lancet i, 237–240.CrossRefGoogle Scholar
Serjeant, G. R., Topley, J. M., Mason, K., Serjeant, B. E., Pattison, J. R., Jones, S. E. & Mohamed, R. (1981). Outbreak of aplastic crisis in sickle cell anaemia associated with parvovirus-like agent. Lancet ii, 595–598.CrossRefGoogle Scholar
Schneerson, J. M., Mortimer, P. P. & Vandervelde, E. M. (1980). Febrile illness due to a parvovirus. British Medical Journal 2, 1580.CrossRefGoogle Scholar
Wallace, J., Milne, G. R. & Barr, A. (1972). Total screening of blood donations for Australia (hepatitis associated) antigen and its antibody. British Medical Journal i, 663.CrossRefGoogle Scholar